2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one

C20H28N6O2 — CID 70775277

IUPAC2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one
SMILESCc1nc2nc(CN3CCC4(CCC(=O)N(CC5CC5)C4)CC3)cc(=O)n2[nH]1
InChIInChI=1S/C20H28N6O2/c1-14-21-19-22-16(10-18(28)26(19)23-14)12-24-8-6-20(7-9-24)5-4-17(27)25(13-20)11-15-2-3-15/h10,15H,2-9,11-13H2,1H3,(H,21,22,23)
InChIKeyDKZITZQXTTUZPU-UHFFFAOYSA-N
MW384.48 g/mol
LogP1.34
Rot. Bonds4

About 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one

2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one (PubChem CID 70775277) has the molecular formula C20H28N6O2 and a molecular weight of 384.48 g/mol. Its IUPAC name is 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one.

Molecular Properties

Compound Name2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one
PubChem CID70775277
Molecular FormulaC20H28N6O2
Molecular Weight384.48 g/mol
Exact Mass384.23
IUPAC Name2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one
SMILESCc1nc2nc(CN3CCC4(CCC(=O)N(CC5CC5)C4)CC3)cc(=O)n2[nH]1
InChIInChI=1S/C20H28N6O2/c1-14-21-19-22-16(10-18(28)26(19)23-14)12-24-8-6-20(7-9-24)5-4-17(27)25(13-20)11-15-2-3-15/h10,15H,2-9,11-13H2,1H3,(H,21,22,23)
InChIKeyDKZITZQXTTUZPU-UHFFFAOYSA-N
XLogP1.34
TPSA86.60 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500384.48
LogP ≤ 51.34
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one?
The IUPAC name of 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one (CID 70775277) is 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one.
What is the SMILES notation for 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one?
The canonical SMILES for 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one is Cc1nc2nc(CN3CCC4(CCC(=O)N(CC5CC5)C4)CC3)cc(=O)n2[nH]1.
What is the InChIKey of 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one?
The InChIKey is DKZITZQXTTUZPU-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H28N6O2/c1-14-21-19-22-16(10-18(28)26(19)23-14)12-24-8-6-20(7-9-24)5-4-17(27)25(13-20)11-15-2-3-15/h10,15H,2-9,11-13H2,1H3,(H,21,22,23).
What are the key properties of 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one?
2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one has a molecular weight of 384.48 g/mol, XLogP of 1.34, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(cyclopropylmethyl)-9-[(2-methyl-7-oxo-1H-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-3-one is sourced from PubChem (CID 70775277), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).